Recruitment Assessment in Patients With Acute Respiratory Distress Syndrome and Covid-19

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT05248243

Recruitment Status : Recruiting

First Posted : February 21, 2022

Last Update Posted : March 10, 2023

See Contacts and Locations

View this study on Beta.ClinicalTrials.gov

Sponsor:

Information provided by (Responsible Party):

Roberto Santa Cruz, Ramos Mejía Hospital

Study Description

Brief Summary:

Respiratory failure associated with Covid-19 can be expressed as acute respiratory distress syndrome (ARDS), which is an acute inflammatory lung injury,which generally requires the use of invasive mechanical ventilation (MV). There are inconclusive results regarding the potential lung recruitment in ARDS. Recently, a new index based on lung compliance has been described to directly quantify the potential for lung recruitment, called the recruitment-inflation index (R/I index). The objective of this study is to prospectively evaluate the recruitment capacity in patients with ARDS and ARDS-Covid-19.

Condition or disease	Intervention/treatment
Acute Respiratory Distress Syndrome COVID-19 Pneumonia Recruitment	Procedure: Recruitment assessment

Show detailed description

Detailed Description:

During the first 7 days of the patient on mechanical ventilation (MV), measurements will be taken. For this, the patient will be in the supine position (DS) or the prone position (DP). The patient will be on a dose of analgesics, under sedation and muscle relaxation and will not present any respiratory stimulus.

Data from MV will also be recorded (prior to recruitment assessment): tidal volume (TV) in milliliters (ml), respiratory rate (RR) in a minute, fraction of inspired oxygen (FiO2), positive end-expiratory pressure (PEEP), in centimeters of water (cmH2O), plateau pressure (Pplat, measured after an end-inspiratory pause, cmH2O), mean airway pressure (PM, cmH2O), minute volume (calculated as the product of RR and TV) in milliliters per minute, ∆P (calculated as Pplat minus PEEP, cmH2O), static compliance (calculated as TV divided by ∆P, ml/cmH2O). Arterial blood gases will also be considered. The proposed recruitment assessment (R/I index) will be compared with another already validated method to evaluate recruitment, such as the measurement of pulmonary hysteresis ratio.For measurements, a ventilator (Neumovent GraphNet Advance-TS, Córdoba Argentina) will be used. Additionally, a dedicated software connected to a computer will be used to perform the measurements.

The following will be assessed: presence of autoPEEP, preset inspiratory tidal volume (TVi), TV exhaled by the ventilator (TVexh) and TV exhaled from high to low PEEP (difference of 10 cm of H2O),during a single maneuver (TVeHL). The measurement will be performed with a high level of PEEP (PEEPH), with values between 15 and 18 cmH2O and a low level of PEEP (PEEPL) with values between 5 and 8 cmH2O. Pplat in PEEPL will also be measured. Additionally, an attempt will be made to determine if there is complete airway closure (a confounder for measurement of alveolar pressure). This is because there are patients who have complete airway closure. In this case, the lungs required an airway opening pressure (AOP) to reopen airways before initiating lung inflation. When AOP is higher than PEEPL, the AOP will be considered as the lower pressure value (instead of PEEPL).

The recruitment index (R/I index) will be as follows:

R/I = (TVexHL - TVexH)/TVi X (Ppl - PEEPL/PEEPH - PEEPL) - 1

TVexH: TV exhaled with PEEPH.

In case of airway closure PEEPL will be replaced by AOP.

A threshold of 0.5 was used to deﬁne high recruitability (R/I ratio >= 0.5) and low recruitability (R/I ratio < 0.5).

The evaluation of pressure in relation to volume will also be carried out, through the pressure/volume curve (PV curve), available in the respirator. A low-flow inflation and deflation PV curve from 0 up to 40 cm H2O and from 40 down to 0 cm H2O will be performed using the automatic tool on the ventilator (P/V tool; Neumovent GraphNet Advance-ts, Córdoba Argentina). The P-V curve can be visualized immediately on the screen of the mechanical ventilator and will be taken as a reference method to assess lung recruitment through the hysteresis-like behavior of the respiratory system. Inﬂation and deﬂation volume data will be corrected for changes in oxygen consumption.

Ratio hysteresis of the respiratory system will be measured by planimetry using SigmaPlot 12.0 software. There, through a cursor, for the measurement of hysteresis, the place where the volume was greater was drawn and the coincident pressure value was considered. Subsequently the ratio hysteresis was calculated as the ratio between hysteresis and the product of the pressure span and the maximum volume reached (maximum hysteresis). Recruitment potential will be considered if this relationship presents a value > 28%.

Data Analysis. Categorical variables will be presented as number and percentage, while continuous variables will be presented as mean and standard deviation or median and interquartile range, as appropriate. The Chi2 test or Fisher's exact test will be used for qualitative variables and the Student test or the Mann-Whitney U test for quantitative variables. To evaluate correlation, the Pearson or Spearman test will be used, according to the distribution of the evaluated variables. A p ≤ 0.05 will be used.

Study Design

Layout table for study information

Study Type :	Observational
Estimated Enrollment :	41 participants
Observational Model:	Cohort
Time Perspective:	Prospective
Official Title:	Recruitment Assessment in Patients With Acute Respiratory Distress Syndrome and Covid-19
Actual Study Start Date :	March 7, 2022
Actual Primary Completion Date :	March 7, 2023
Estimated Study Completion Date :	March 1, 2025

Resource links provided by the National Library of Medicine

MedlinePlus related topics: COVID-19 (Coronavirus Disease 2019) Health Checkup

Genetic and Rare Diseases Information Center resources: Respiratory Distress Syndrome, Infant Acute Respiratory Distress Syndrome Acute Graft Versus Host Disease

U.S. FDA Resources

Groups and Cohorts

Intervention Details:

Procedure: Recruitment assessment
TV exhaled from high to low PEEP (difference of 10 cm of H2O),during a single maneuver (TVeHL). The measurement will be performed with a high level of PEEP (PEEPH), with values between 15 and 18 cmH2O and a low level of PEEP (PEEPL) with values between 5 and 8 cmH2O. Pplat in PEEPL will also be measured.

Outcome Measures

Primary Outcome Measures :

Potential recruitment of patients with ARDS and ARDS-Covid-19 [ Time Frame: First 7 days of the patient on mechanical ventilation (MV) ]
To determine the Recruitment Index (R/I) of patients with ARDS and ARDS-Covid-19.

Tidal volume and pressure will be combined to report the Recruitment Index (R/I) in mL/cmH2O.

A threshold of 0.5 will be used to deﬁne high recruitability (R/I ratio >= 0.5 ml/cmH2O) and low recruitability (R/I ratio < 0.5 ml/cmH2O).

Secondary Outcome Measures :

To compare the potential recruitment in the supine position (SD) and in the prone position (PD). [ Time Frame: First 7 days of the patient on mechanical ventilation (MV) ]
To compare the R/I (ml/cmH2O) in patients with ARDS and ARDS-Covid-19 in the supine position (SD) and in the prone position (PD).

Tidal volume and pressure will be combined to report the Recruitment Index (R/I) in mL/cmH2O.

A threshold of 0.5 will be used to deﬁne high recruitability (R/I ratio >= 0.5 ml/cmH2O) and low recruitability (R/I ratio < 0.5 ml/cmH2O).
Correlation between recruitment index (RI) and recruitment assessed by hysteresis ratio. [ Time Frame: First 7 days of the patient on mechanical ventilation (MV) ]
Assess the correlation between recruitment index (RI) and recruitment assessed by the hysteresis ratio (hysteresis and the product of the pressure span and the maximum volume reached (maximum hysteresis) in ml/cmH2O

Tidal volume and pressure will be combined to report the Recruitment Index (R/I) in mL/cmH2O.

Tidal volume and pressure will be combined to report the hysteresis ratio in mL/cmH2O.
Assess the relationship between potential recruitment with respiratory parameters. [ Time Frame: First 7 days of the patient on mechanical ventilation (MV) ]
Assess the correlation between IR and respiratory parameters
- Oxygenation: PaO2/FiO2 (ratio between arterial oxygen pressure and inspired fraction of oxygen).
- Static compliance (cmH2O)
- Plateau pressure (cmH2O)
- ∆P (ml/cmH2O)
Tidal volume and pressure will be combined to report the Recruitment Index (R/I) in mL/cmH2O.
Assess the relationship between potential recruitment and clinical parameters. [ Time Frame: First 7 days of the patient on mechanical ventilation (MV) ]
Assess the correlation between IR and clinical parameters:
- Symptom onset date (FIS) (in case of ARDS-Covid-19)
- APACHE II (Acute Physiology And Chronic Health Evaluation) score
- SOFA (Sequential Organ Failure Assessment Score) score
- Ventilator free days (in days)
Tidal volume and pressure will be combined to report the Recruitment Index (R/I) in mL/cmH2O.

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information

Ages Eligible for Study:	15 Years and older (Child, Adult, Older Adult)
Sexes Eligible for Study:	All
Accepts Healthy Volunteers:	No
Sampling Method:	Non-Probability Sample

Study Population

Patients 15 years of age or older who have been receiving MV in the first 7 days and have been defined as ARDS and ARDS-Covid-19 (with a positive polymerase chain reaction in nasopharyngeal swab samples) according to the clinical criteria of the Berlin definition.

Criteria

Inclusion Criteria:

- Patients who have been receiving MV with diagnosis of ARDS (Berlin definition) and ARDS-Covid-19.

Exclusion Criteria:

Patients with chronic pulmonary disease
Patients with a high risk of death within 3 months for reasons other than ARDS-Covid-19
Patients having made the decision to withhold life-sustaining treatment.

Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT05248243

Contacts

Layout table for location contacts

Contact: Roberto Santa Cruz, Dr.	+5492966559019	resc.hrrg@gmail.com

Locations

Layout table for location information

Argentina
Hospital Agudos Ramos Mejía	Recruiting
Ciudad Autonoma de Buenos Aire, Buenos Aires, Argentina, C1221ADC
Contact: Roberto Santa Cruz, Dr. +5492966559019 resc.hrrg@gmail.com

Sponsors and Collaborators

Ramos Mejía Hospital

More Information

Publications of Results:

Chen L, Del Sorbo L, Grieco DL, Junhasavasdikul D, Rittayamai N, Soliman I, Sklar MC, Rauseo M, Ferguson ND, Fan E, Richard JM, Brochard L. Potential for Lung Recruitment Estimated by the Recruitment-to-Inflation Ratio in Acute Respiratory Distress Syndrome. A Clinical Trial. Am J Respir Crit Care Med. 2020 Jan 15;201(2):178-187. doi: 10.1164/rccm.201902-0334OC.

Chiumello D, Arnal JM, Umbrello M, Cammaroto A, Formenti P, Mistraletti G, Bolgiaghi L, Gotti M, Novotni D, Reidt S, Froio S, Coppola S. Hysteresis and Lung Recruitment in Acute Respiratory Distress Syndrome Patients: A CT Scan Study. Crit Care Med. 2020 Oct;48(10):1494-1502. doi: 10.1097/CCM.0000000000004518. Erratum In: Crit Care Med. 2022 Mar 1;50(3):e339.

Demory D, Arnal JM, Wysocki M, Donati S, Granier I, Corno G, Durand-Gasselin J. Recruitability of the lung estimated by the pressure volume curve hysteresis in ARDS patients. Intensive Care Med. 2008 Nov;34(11):2019-25. doi: 10.1007/s00134-008-1167-8. Epub 2008 Jun 25.

Pan C, Chen L, Lu C, Zhang W, Xia JA, Sklar MC, Du B, Brochard L, Qiu H. Lung Recruitability in COVID-19-associated Acute Respiratory Distress Syndrome: A Single-Center Observational Study. Am J Respir Crit Care Med. 2020 May 15;201(10):1294-1297. doi: 10.1164/rccm.202003-0527LE. No abstract available.

Chen L, Del Sorbo L, Grieco DL, Shklar O, Junhasavasdikul D, Telias I, Fan E, Brochard L. Airway Closure in Acute Respiratory Distress Syndrome: An Underestimated and Misinterpreted Phenomenon. Am J Respir Crit Care Med. 2018 Jan 1;197(1):132-136. doi: 10.1164/rccm.201702-0388LE. No abstract available.

Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med. 1985 Oct;13(10):818-29.

Vincent JL, de Mendonca A, Cantraine F, Moreno R, Takala J, Suter PM, Sprung CL, Colardyn F, Blecher S. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on "sepsis-related problems" of the European Society of Intensive Care Medicine. Crit Care Med. 1998 Nov;26(11):1793-800. doi: 10.1097/00003246-199811000-00016.

Schoenfeld DA, Bernard GR; ARDS Network. Statistical evaluation of ventilator-free days as an efficacy measure in clinical trials of treatments for acute respiratory distress syndrome. Crit Care Med. 2002 Aug;30(8):1772-7. doi: 10.1097/00003246-200208000-00016.

Other Publications:

ARDS Definition Task Force; Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, Fan E, Camporota L, Slutsky AS. Acute respiratory distress syndrome: the Berlin Definition. JAMA. 2012 Jun 20;307(23):2526-33. doi: 10.1001/jama.2012.5669.

Ziehr DR, Alladina J, Petri CR, Maley JH, Moskowitz A, Medoff BD, Hibbert KA, Thompson BT, Hardin CC. Respiratory Pathophysiology of Mechanically Ventilated Patients with COVID-19: A Cohort Study. Am J Respir Crit Care Med. 2020 Jun 15;201(12):1560-1564. doi: 10.1164/rccm.202004-1163LE. No abstract available.

Gattinoni L, Caironi P, Cressoni M, Chiumello D, Ranieri VM, Quintel M, Russo S, Patroniti N, Cornejo R, Bugedo G. Lung recruitment in patients with the acute respiratory distress syndrome. N Engl J Med. 2006 Apr 27;354(17):1775-86. doi: 10.1056/NEJMoa052052.

Marini JJ, Gattinoni L. Management of COVID-19 Respiratory Distress. JAMA. 2020 Jun 9;323(22):2329-2330. doi: 10.1001/jama.2020.6825. No abstract available.

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Hohmann F, Wedekind L, Grundeis F, Dickel S, Frank J, Golinski M, Griesel M, Grimm C, Herchenhahn C, Kramer A, Metzendorf MI, Moerer O, Olbrich N, Thieme V, Vieler A, Fichtner F, Burns J, Laudi S. Early spontaneous breathing for acute respiratory distress syndrome in individuals with COVID-19. Cochrane Database Syst Rev. 2022 Jun 29;6(6):CD015077. doi: 10.1002/14651858.CD015077.

Layout table for additonal information

Responsible Party:	Roberto Santa Cruz, Principal Investigator, Ramos Mejía Hospital
ClinicalTrials.gov Identifier:	NCT05248243
Other Study ID Numbers:	Hospital General Ramos Mejía
First Posted:	February 21, 2022 Key Record Dates
Last Update Posted:	March 10, 2023
Last Verified:	March 2023
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD:	No

Layout table for additional information

Studies a U.S. FDA-regulated Drug Product:	No
Studies a U.S. FDA-regulated Device Product:	No

Additional relevant MeSH terms:

Layout table for MeSH terms

COVID-19 Respiratory Distress Syndrome Respiratory Distress Syndrome, Newborn Acute Lung Injury Syndrome Disease Pathologic Processes Respiratory Tract Infections Infections Pneumonia, Viral Pneumonia	Virus Diseases Coronavirus Infections Coronaviridae Infections Nidovirales Infections RNA Virus Infections Lung Diseases Respiratory Tract Diseases Respiration Disorders Infant, Premature, Diseases Infant, Newborn, Diseases Lung Injury

To Top